Vaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb Application

27.09.2023 - Phase 1b/2 pepinemab/PDAC study update to be presented on September 29 at special AACR meeting New ActivMAb application to be reviewed on September 28 at CHI's 20th Annual Discovery on Target (DOT) conference ROCHESTER, N.Y., Sept. ... Seite 1

Related Keywords

United States ,Luis Ruffolo ,Gateway Discovery Award Conquer Cancer Foundation ,Bayesian Optimal Interval ,Gateway Discovery Award ,Conquer Cancer ,Rochester Cancer Center ,Wilmot Cancer Institute ,Vaccinex Chart ,Accinex Kurs ,Accinex Aktie ,